Grepid Európai Unió - angol - EMA (European Medicines Agency)

grepid

pharmathen s.a. - clopidogrel (as besilate) - peripheral vascular diseases; stroke; myocardial infarction - antithrombotic agents - prevention of atherothrombotic eventsclopidogrel is indicated in:adult patients suffering from myocardial infarction (from a few days until less than 35 days), ischaemic stroke (from seven days until less than six months) or established peripheral arterial disease;adult patients suffering from acute coronary syndrome:non-st-segment-elevation acute coronary syndrome (unstable angina or non-q-wave myocardial infarction), including patients undergoing a stent placement following percutaneous coronary intervention, in combination with acetylsalicylic acid (asa);st-segment-elevation acute myocardial infarction, in combination with asa in medically treated patients eligible for thrombolytic therapy.prevention of atherothrombotic and thromboembolic events in atrial fibrillationin adult patients with atrial fibrillation who have at least one risk factor for vascular events, are not suitable for treatment with vitamin-k antagonists and who have a low bleeding risk, clopidogrel is indicated in combination with asa for the prevention of atherothrombotic and thromboembolic events, including stroke.

Lovtelar 800 mg film-coated tablets Írország - angol - HPRA (Health Products Regulatory Authority)

lovtelar 800 mg film-coated tablets

pharmathen s.a. - sevelamer carbonate - film-coated tablet - sevelamer

Latanoprost/Timolol Pharmathen 50 µg/ml - 5 mg/ml eye drops sol. pump Belgium - angol - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

latanoprost/timolol pharmathen 50 µg/ml - 5 mg/ml eye drops sol. pump

pharmathen s.a. - timolol maleate 6,83 mg/ml - eq. timolol 5 mg/ml; latanoprost 50 µg/ml - eye drops, solution - 50 µg/ml - 5 mg/ml - latanoprost 50 µg/ml; timolol maleate 6.83 mg/ml - timolol, combinations

Fingolimod Pharmathen 0,5 mg hard caps. Belgium - angol - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

fingolimod pharmathen 0,5 mg hard caps.

pharmathen s.a. - fingolimod hydrochloride 0,56 mg - eq. fingolimod 0,5 mg - capsule, hard - 0,5 mg - fingolimod hydrochloride 0.56 mg - fingolimod

Deferasirox Pharmathen 90 mg film-coat. tabl. Belgium - angol - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

deferasirox pharmathen 90 mg film-coat. tabl.

pharmathen s.a. - deferasirox 90 mg - film-coated tablet - 90 mg - deferasirox 90 mg - deferasirox